Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2015 May 21;3(4):566–575.e1. doi: 10.1016/j.jaip.2015.04.002

Table 5.

Associations of OSA risk* with blood and airway inflammatory markers in subjects with asthma.

Univariate Analyses Multivariate Analyses
Parameter estimate (95% CI) p-value Parameter estimate (95% CI) p-value
Log IgE -0.04 (-0.16, 0.07) 0.42 -0.12 (-0.28, 0.03) 0.11
Blood eos count -0.001 (-0.04, 0.03) 0.94 -0.004 (-0.05, 0.04) 0.87
Blood Eosinophils% -0.12 (-0.55, 0.32) 0.60 0.01 (-0.57, 0.59) 0.97
eNO -3.43 (-10.21, 3.35) 0.32 -0.30 (-9.14, 8.54) 0.94
Sputum Eosinophils % 0.61 (-1.24, 2.45) 0.52 0.28 (-2.27, 2.82) 0.83
Sputum PMNs% 5.68 (1.76, 9.60) 0.005 7.78 (2.33, 13.22) 0.006
*

Sleep Apnea scale of the Sleep Disorders Questionnaire score normalized by its standard deviation.

Analyses used general linear models.

Adjusted for obesity, smoking history (yes/no) and any (inhaled or systemic) current corticosteroid use.

Abbreviations: CI= confidence interval; eNO=fraction of exhaled nitric oxide; PMNs=polymorphonuclear neutrophils.